Tandem closes IPO; Particle Sciences to develop nasal brain injury formulation for BHR Pharma;

> Tandem Diabetes Care ($TNDM) closed its IPO of 9.2 million shares at $15 per share. More (sub. req.)

> BHR Pharma tapped delivery tech company Particle Sciences to develop and manufacture a nasal formulation of progesterone for traumatic brain injury. More

> 3M Drug Delivery Systems will provide a matrix patch for the transdermal delivery of the opioid pain medication fentanyl to German company STADA Arzneimittel AG. More

> Nonprofit research institute CBSET has installed GE Healthcare's ($GE) Innova 3-D imaging system for real-time interventional imaging that also allows for drug delivery capabilities. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.